Corrigendum: Comprehensive pan-cancer analysis of the prognostic and immunological roles of METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C axis.

Jiang, Xiulin; Yuan, Yixiao; Tang, Lin; Wang, Juan; Liu, Qianqian; Zou, Xiaolan; Duan, Lincan

Jiang, Xiulin; Yuan, Yixiao; Tang, Lin; Wang, Juan; Liu, Qianqian; Zou, Xiaolan; Duan, Lincan.

Afiliación

Jiang X; Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, China.
Yuan Y; Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Tang L; Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Wang J; Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Liu Q; Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Zou X; Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Duan L; Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.

Front Cell Dev Biol ; 10: 1009752, 2022.

Article en En | MEDLINE | ID: mdl-36225317

Palabras clave

SNHG1; UBE2C; drug sensitivity; immune cell infiltration; m6A modification; miRNA-140-3p; pan-cancer; prognosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Cell Dev Biol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google